NasdaqCM - Nasdaq Real Time Price USD
Cardio Diagnostics Holdings, Inc. (CDIO)
At close: November 22 at 4:00 PM EST
After hours: 7:57 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
35.6880
17.0650
0.9500
0.9010
--
Operating Expense
8,427.1610
7,259.5240
4,549.4010
621.3490
609.1640
Operating Income
-8,391.4730
-7,242.4590
-4,548.4510
-620.4480
-609.1640
Net Non Operating Interest Income Expense
-110.4700
-6,733.9450
--
--
--
Other Income Expense
--
5,599.5700
-112.5340
--
4.0000
Pretax Income
-8,253.0740
-8,376.8340
-4,660.9850
-620.4480
-605.1640
Net Income Common Stockholders
-8,253.0740
-8,376.8340
-4,660.9850
-620.4480
-605.1640
Diluted NI Available to Com Stockholders
-8,253.0740
-8,376.8340
-4,660.9850
-620.4480
-605.1640
Basic EPS
-0.30
-0.66
-1.51
-0.07
-0.06
Diluted EPS
-0.30
-0.66
-1.51
-0.07
-0.06
Basic Average Shares
21,792.0000
12,685.1330
3,087.6830
9,514.7430
9,514.7430
Diluted Average Shares
21,792.0000
12,685.1330
3,087.6830
9,514.7430
9,514.7430
Total Operating Income as Reported
-8,391.4730
-7,242.4590
-4,548.4510
-620.4480
-609.1640
Total Expenses
8,427.1610
7,259.5240
4,549.4010
621.3490
609.1640
Net Income from Continuing & Discontinued Operation
-8,253.0740
-8,376.8340
-4,660.9850
-620.4480
-605.1640
Normalized Income
-8,501.9430
-13,976.4040
-4,548.4510
-620.4480
-605.1640
Interest Income
1.1440
1.0680
--
--
--
Interest Expense
111.6140
6,735.0130
--
--
--
Net Interest Income
-110.4700
-6,733.9450
--
--
--
EBIT
-8,141.4600
-1,641.8210
-4,660.9850
-620.4480
-609.1640
EBITDA
-7,887.6700
-1,530.2010
-4,644.9850
-604.4480
-598.4970
Reconciled Depreciation
253.7900
111.6200
16.0000
16.0000
10.6670
Net Income from Continuing Operation Net Minority Interest
-8,253.0740
-8,376.8340
-4,660.9850
-620.4480
-605.1640
Total Unusual Items Excluding Goodwill
248.8690
5,599.5700
-112.5340
--
--
Total Unusual Items
248.8690
5,599.5700
-112.5340
--
--
Normalized EBITDA
-8,136.5390
-7,129.7710
-4,532.4510
-604.4480
-598.4970
12/31/2020 - 1/14/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ZVSA ZyVersa Therapeutics, Inc.
1.1300
-0.88%
SPRC SciSparc Ltd.
0.2453
-14.29%
CNSP CNS Pharmaceuticals, Inc.
0.1244
-4.31%
NKGN NKGen Biotech, Inc.
0.3500
+3.70%
ADTX Aditxt, Inc.
0.3389
+4.44%
ENSC Ensysce Biosciences, Inc.
0.4300
-27.41%
BDRX Biodexa Pharmaceuticals Plc
4.5700
+3.86%
ICU SeaStar Medical Holding Corporation
2.0500
-6.82%
PXMD PaxMedica, Inc.
0.0995
+42.14%
SLXN Silexion Therapeutics Corp
0.3070
-4.18%